Code-evolver Stories

Codexis is a necessary but infamous biotech company that has recently taken a big hit in the market losing much of its support by big financial institutions and now only the true believers, insiders, and idealists remain. Can Codexis make a comeback after the stock market rules allow its insiders to trade again on Tuesday November 11th, 2025, or will it continue to flounder. Let's dive into Codexis and its baffling array of problems and its ray of hope.